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Abstract
Background: Dual energy CT (DECT) has proven its potential in oncological imaging. Considering the repeated
follow-up examinations, radiation dose should not exceed conventional single energy CT (SECT). Comparison
studies on the same scanner with a large number of patients, considering patient geometries and image quality,
and exploiting full potential of SECT dose reduction are rare. Purpose of this retrospective study was to compare
dose of dual source DECT versus dose-optimized SECT abdominal imaging in clinical routine.
Methods: One hundred patients (62y (±14)) had either contrast-enhanced SECT including automatic voltage
control (44) or DECT (56). CT dose index (CTDIvol), size-specific dose-estimate (SSDE) and dose-length product (DLP)
were reported. Image noise (SD) was recorded as mean of three ROIs placed in subcutaneous fat and normalized to
dose by SDn ¼ SD ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃCDTIvolp . For dose-normalized contrast-to-noise ratio (CNRD), mean attenuation of psoas muscle
(CTmuscle) and subcutaneous fat (CTfat) were compared by CNRD = (CTmuscle − CTfat)/SDn. Statistical significance was
tested with two-sided t-test (α = 0.05).
Results: There was no significant difference (p < 0.05) between DECT and SECT: Mean CTDIvol was 14.2 mGy (±3.9)
(DECT) and 14.3 mGy (±4.5) (SECT). Mean DLP was 680 mGy*cm (±220) (DECT) and 665 mGy*cm (±231) (SECT). Mean
SSDE was 15.7 mGy (±1.9) (DECT) and 16.1 mGy (±2.5) (SECT). Mean SDn was 42.2 (±13.9) HU  ﬃﬃﬃﬃﬃﬃﬃﬃﬃmGyp (DECT) and 47.8
(±14.9) HU  ﬃﬃﬃﬃﬃﬃﬃﬃﬃmGyp (SECT). Mean CNRD was 3.9 (±1.3) mGy−12. (DECT) and 4.0 (±1.3) mGy−12 (SECT).
Conclusion: Abdominal DECT is feasible without increasing radiation dose or deteriorating image quality, even
compared to dose-optimized SECT including automatic voltage control. Thus DECT can contribute to sophisticated
oncological imaging without dose penalty.
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Background
Dual energy computed tomography (DECT) is an exciting
development in CT technology and has multiple clinical
benefits [1–4]. Applications include characterization of
renal stones [5–7], visualization of lung perfused blood
volume and ventilation [8–11] as well as assessment of
myocardial perfused blood volume [12–14]. In oncological
imaging, DECT has proven potential for detection and
characterization of liver and kidney masses [15, 16],
characterization of pulmonary nodules [17] and therapy
monitoring [18–20].
Considering that oncological patients have repeated
follow-up examinations, dose issues should not be
neglected. It is suggested that about 2 % of all cancers in
the US are caused by radiation exposure from CT [21].
Some authors make attempts to predict the effect of ra-
diation dose, e.g., that 29 000 patients will have cancer
due to the CT examinations performed 2007 in US [22].
Another study estimates, that 1 of 270 women getting a
CT of the coronary arteries will suffer from cancer
caused by this examination [23]. In this context,
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convincing evidence is needed proving that advanced
DECT applications do not require increased radiation
exposure.
There are previous studies and reviews comparing
dose of DECT and conventional single energy CT
(SECT) [24–30] for different examination types. How-
ever, studies in clinical routine with a large number of
patients, taking into account patient geometries and
image quality, on the same scanner and exploiting the
full potential of dose reduction of SECT including auto-
matic voltage control are rare. Results of previous inves-
tigations are still controversial. Current studies indicate
a potential compromise of image quality for DECT, in
contrast to many previous investigations suggesting that
DECT offers comparable signal to noise ratios when
compared to SECT [31]. This demonstrates the need of
further studies evaluating DECT dose efficiency, espe-
cially in clinical routine.
The purpose of this study was to compare radiation
dose of abdominal DECT versus dose-optimized SECT
including tube current and voltage modulation on the
identical dual source CT in clinical routine, considering
patient geometries and image quality.
Methods
Patient population
This retrospective study was approved by local ethics
committee (Ethics committee of Medical Faculty of
Heidelberg), and informed consent was obtained from
all patients.
Over a period of 6 weeks (March 2015–April 2015)
100 CT scans (44 SECT, 56 DECT) of 100 oncological
patients were evaluated (mean age, weight, height and
body mass index are listed in Table 1).
Inclusion criteria were
 Routine examination in the mentioned time period
(March 2015–April 2015)
 Protocol parameter as described in the following
paragraph.
CT examination
Spiral image acquisition was performed on a second-
generation 2 × 64-slice dual source dual energy CT
(Somatom Definition Flash, Siemens Healthcare Sector,
Forchheim, Germany). Two x-ray tubes, mounted with
an angular off-set of 95o, rotate around the patient. The
scanner offers different scan modes, among two investi-
gated in this study:
(1)DECT was performed by using two different tubes
voltages (100 kV and tin filtered 140 kV (Sn140 kV),
reference tube currents 200/155 mAs) and online
dose modulation (CARE Dose 4D, Siemens). The
scan was acquired with a detector collimation of
32 × 0.6 mm in craniocaudal direction (pitch 0.6).
3 mm slices were reconstructed using a standard
soft tissue reconstruction kernel (standard filtered
back projection B31f medium smooth). With a
weighting factor of 0.5 the two datasets from the
two tubes were fused to virtual images
corresponding to a 120 kV scan.
(2)SECT was performed with online dose modulation
and automatic voltage control (CARE Dose 4D and
CarekV, Siemens). The reference tube current was
255 mAs, the reference tube voltage 120 kV. The
scan was acquired with a detector collimation of
64 × 0.6 mm in craniocaudal direction (pitch 0.6).
3 mm slices were reconstructed using a standard
soft tissue reconstruction kernel (standard filtered
back projection B31f medium smooth).
Examination protocol included intravenous application
of nonionic iodinated contrast medium (Imeron 300,
Bracco, Konstanz, Germany) with a body weight adapted
amount and flow rate (see Table 2) via an automated in-
jector. Portal venous images were acquired (bolus-tracking
technique) with a scan range from upper abdomen to the
inguinal region (approximately 3 cm distal to the
symphysis).
Data analysis
For each scan, several dosimetry parameters were re-
ported. Most common are the computed tomography
dose index (CTDIvol) and the dose length product (DLP).
CTDIvol refers to a 32 cm PMMA phantom [32–34].
Although CTDIvol is a useful parameter for characterizing
radiation output of the scanner, it is not the patient dose
[35]. It underestimates dose for small- and overestimates
dose for large patients. To take into consideration patient
Table 1 Patient population










All 100 61.6 (±13.6) 80.7 (±17.1) 173.2 (±10.4) 26.8 (±4.9) 36.9 (±5.3)
DECTb 56 60.3 (±12.8) 83.9 (±18.0) 175.9 (±10.3) 27.0 (±4.8) 37.2 (±5.5)
SECTc 44 63.2 (±14.6) 76.6 (±15.2) 169.9 (±9.5) 26.6 (±5.1) 36.6 (±5.1)
Values are given as means (± standard deviation)
abody mass index; bdual energy CT; csingle energy CT
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geometry, the American Association of Physicists in
Medicine has introduced size-specific dose estimates
(SSDE) [36].
SSDE is based on the diameter of the patient (anterior-
posterior, lateral or effective). Diameter can be measured
on the patient or determined on a radiograph/CT-
topogram. Tables with conversion factors (f) for different
diameters between 10 and 45 cm are available. These fac-
tors are determined based on data of four research groups
working with different methods (phantoms as well as
Monte Carlo simulations). CTDIvol given in standard
dose protocols can be corrected with the conversion fac-
tors by SSDE =CTDIvol ⋅ f. For this study, the maximal
lateral diameter of abdomen was determined on CT-
topogram (Fig. 1). For 5 patients (3 DECT, 2 SECT) SSDE
could not be determined because lateral diameter was
above 45 cm and thus not listed in the conversion factor
table.
DECT as well as SECT protocols were set up for clin-
ical routine in order to meet the radiologists demands
for good image quality at reasonable radiation exposure.
The reconstructed images found a broad acceptance in
clinical routine for more than 1 year. For this retrospect-
ive study, the clinical acceptance was supplemented by
the objective parameters image noise and contrast-to-
noise ratio, normalized to dose (CNRD).
Image noise (standard deviation (SD) of CT number)
was recorded as the mean measurement of three ROIs
placed in the subcutaneous fat of anterior, posterior and
lateral abdominal wall (Fig. 2). For all measurements, the
size of the ROI was between 15 and 50 mm2. Image noise
was normalized because the X-ray generation of the X-ray
tube is a random Poisson process. The measured number
of photons in the detector will vary from the mean ap-
proximately as the inverse square root of the mean num-
ber of photons [37], which can be roughly approximated
by the inverse square root of CTDIvol. According to this
relation, CT noise measured in this study was normalized





For CNRD, mean CT attenuation numbers of
psoas muscle were obtained by placing a circular
ROI (15–50 mm2) in right and left psoas muscle and cal-
culating the mean of both values (CTmuscle). Attenuation
of muscle tissue was compared to mean attenuation
(CTfat) and normalized noise of subcutaneous fat by:
CNRD = (CTmuscle −CTfat)/SDn.
Statistical significance was tested with two-sided t-test
(significance level α = 0.05). Quantitative variables are
expressed as mean with standard deviation.
Results and discussion
Results
There was no significant difference (significance level
α = 0.05) between the investigated radiation dose sur-
rogates (Table 3):
Mean CTDIvol for all scans was 14.2 (±4.2) mGy.
Mean CTDIvol for DECT was 14.2 (±3.9) mGy and 14.3
(±4.5) mGy for SECT.
Mean DLP for all scans was 674 (±224) mGy*cm.
Mean DLP for DECT was 680 (±220) mGy*cm and 665
(±231) mGy*cm for SECT.
Patient-specific corrections did not change this result:
Mean SSDE was 15.9 (±2.2) mGy for all scans. Mean
SSDE for DECT was 15.7 (±1.9) mGy and 16.1 (±2.5)
mGy for SECT.
Evaluation of noise, normalized to CTDIvol (SDn),
revealed no significant difference between DECT and
SECT:











aImeron 300, Bracco, Konstanz, Germany
Fig. 1 Size-specific dose estimates. Lateral patient diameter was
determined on CT-topogram. Based on diameter-dependant conversion
factors (f) and CT dose index (CTDIvol), size-specific dose estimates (SSDE)
can be calculated
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sus 47.8 (±14.9) HU  ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃmGyp for SECT.
Likewise there was no significant difference for CNRD:
Mean CNRD of all scans was 4.0 (±1.3) mGy− 1/2.
Mean CNRD for DECT was 3.9 (±1.3) mGy− 1/2, mean
CNRD for SECT was 4.0 (±1.3) mGy− 1/2.
Table 3 summarizes the evaluated dose parameters,
Fig. 3 demonstrates a graphical overview of CTDIvol,
DLP, SSDE and SDn.
As mentioned before, SECT examinations included
automatic voltage control. The reference tube voltage of
120 kV was modulated for 39 patients to 100 kV.
Discussion
Aim of this study was to investigate radiation exposure
by DECT abdominal imaging compared to dose-
optimized SECT including automatic dose and voltage
modulation in clinical routine, considering patient
geometries and image quality. Results demonstrate that
DECT is feasible without increasing radiation dose or
image noise at comparable contrast-to-noise ratios.
The analysis of several parameters underlines this
statement, among the commonly accepted DLP and
CTDIvol. Mean values from our abdominal examina-
tions (DLP ≤ 680 mGy*cm and CTDIvol ≤ 14.3 mGy)
are, following a report from the European Commission,
below the most common values in Europe (DLP
800 mGy*cm, CTDIvol 25 mGy) [38].
CTDIvol is a dosimetry parameter that represents the
stochastic radiation detriment to a patient, while it is
not accounting for different vulnerabilities of tissue [39].
In contrast, the effective dose reflects the relative risk
from exposure to ionizing radiation. There are different
methods to estimate the effective dose, which were com-
pared in a phantom study using an identical scanner
compared to our study [40]. The authors focused on
chest CT acquired in different scanning modes (SECT
100 kV, 120 kV, 120 kV high pitch mode and DECT
100/Sn140 kV). Protocols were designed CTDIvol-
equivalent compared to the standard 120 kV protocol.
The lowest effective dose was observed for the DECT
protocol (100/Sn140kV), even compared to the standard
SECT 120 kV protocol. Given that this result can be
transferred to abdominal imaging, the comparable
CTDIvol of DECT and SECT measured in this study
could result in a lower effective dose for DECT abdom-
inal scans.
While effective dose reflects tissue vulnerability to ion-
izing radiation, the specific dose estimate (SSDE) takes
into account patient geometry. The corrections based on
patient diameter are motivated by the fact, that CTDIvol
underestimates dose for small- and overestimates dose
for large patients. Consequently, CTDIvol reported for
this study was corrected to SSDE, and no significant
difference between DECT and SECT was observed. A
limitation of this method is, that measuring the diam-
eter of the patient is not standardized. However, meas-
uring the diameter in the centre of the scan length
seems to be a very good approximation (mean square
difference less than 9 %) compared to slice by slice
calculation [41].
Optimizing radiation dose in CT is indispensable, but
at the same time image quality must not be affected.
Fig. 2 Image noise and contrast-to-noise ratio. Left: The image noise (standard deviation (SD) of CT number) was recorded as the mean measurement
of three ROIs placed in the subcutaneous fat of anterior, posterior and lateral abdominal wall (CT fat). Image noise was normalized to CTDIvol
by SDn ¼ SD ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃCDTIvolp . Right: Mean of CT attenuation of right and left psoas muscle (CTmuscle) was used to calculate the contrast-to-noise ratio (CNRD)













All 14.2 (±4.2) 674 (±224) 15.9 (±2.2) 44.7 (±14.5) 4.0 (±1.3)
DECT 14.2 (±3.9) 680 (±220) 15.7 (±1.9) 42.2 (±13.9) 3.9 (±1.3)
SECT 14.3 (±4.5) 665 (±231) 16.1 (±2.5) 47.8 (±14.9) 4.0 (±1.3)
Estimated radiation dose of dual energy (DECT) and single energy (SECT) CT
scans: Computed tomography dose index (CTDIvol), dose length product (DLP),
size-specific dose estimate (SSDE), normalized noise (SDn) and normalized contrast
to noise ratio (CNRD). Values are given as means (± standard deviation). There was
no significant difference for any parameter (p< 0.05)
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The protocols evaluated for this study were set up for
clinical routine in order to meet the radiologists de-
mands for good image quality at reasonable radiation ex-
posure. The broad acceptance of CT images in clinical
routine reflects the data of our study: There was no sig-
nificant difference between DECT and SECT for image
noise and CNRD.
Our results go in line with many previous studies
comparing radiation dose from DECT and SECT. How-
ever, there are some substantial differences in CT proto-
cols and data evaluation compared to our study. In the
following, the key points of previous papers as well as
the difference to our results shall be described:
Purysko et al. performed a retrospective study in some
aspects similar to our study, namely comparing CTDI-
vol, DLP and SSDE as well as noise of abdomen scans
between DECT and SECT. They concluded that DECT
imaging of abdomen can achieve noise levels comparable
to SECT without a dose penalty [26]. In contrast to our
study, information about contrast-to-noise ratio was not
provided. Their main limitation was that SECT and
DECT were performed on different scanners, which
could certainly influence results. Furthermore they did
not use automatic voltage control for SECT, which is a
substantial difference to our study.
Megibow et al. published a best-practice paper and re-
ported that in their clinical routine, DECT without dose
penalty is possible [42]. However, this statement was not
underlined with a statistical evaluation.
Schenzle et al. focused on chest examinations. Their
phantom study revealed equal effective dose for SECT
and DECT in 100/140 kV-mode (2nd generation DECT)
[43]. Comparable to our study, image noise was reported
similar. The main differences to our study are the ana-
tomical region and the evaluation of DECT with phan-
toms, not with patients in clinical routine.
In contrary to our results and the mentioned studies
above, De Cecco et al. reported a minimal dose increase
for DECT [24], without providing any information about
image quality or normalization. The reason could be the




































































Fig. 3 Comparison of radiation dose and image noise. Bar plots of radiation dose parameters and normalized noise (SDn). (CTDIvol: computed
tomography dose index, DLP: dose length product, SSDE: size-specific dose estimates)
Uhrig et al. Cancer Imaging  (2016) 16:15 Page 5 of 8
tube current settings, which were high for DECT (refer-
ence 559 mAs for 80 kV tube and 216 mAs for Sn
140 kV tube) compared to SECT (180 mAs for 120 kV).
A recently published phantom study on dose efficiency
of DECT suggested a compromised contrast to noise ra-
tio for DECT [31]. The authors state that this result ap-
plies specifically to unenhanced soft tissue contrast in a
small adult phantom, in contrast to our study setting
with contrast enhanced scans in clinical routine.
All studies listed above have in common, that SECT
protocols prescribe a fixed tube voltage. But for a fair
dose comparison, the optimum dose for a given patient
size should be chosen for each examination, which was
realized in our study by using automatic voltage control
for SECT.
The mentioned studies were, equally to our study, per-
formed with dual source dual energy CTs. In contrast,
studies with dual energy techniques based on kV switch-
ing show higher doses for DECT [25].
A limitation of this study is that comparisons between
DECT and SECT are not within the same patient. In
contrast to phantom studies, there is a wide variety of
absorption characteristics inevitably coming along with
different patient geometries. Considering that the aim of
this study was evaluating dose exposure in a clinical rou-
tine context, this inhomogeneity had to be accepted. To
face this challenge, patient-specific SSDE was calculated.
A further limitation is that results refer to specific proto-
cols used in our institution, performed with a dual
source CT. There are no comparisons with different CT
scanners or modified protocols.
This study showed that DECT abdominal imaging is
feasible without increasing radiation dose or deteriorat-
ing image quality. Using the higher informational con-
tent of DECT data, radiation dose could even be
decreased. This is possible by replacing true non-
contrast scans with virtual non-contrast scans [44–46].
In addition, CNR can be increased by using nonlinear
image blending or advanced monoenergetic reconstruc-
tion techniques [47, 48]. In particular for patients requir-
ing frequent follow-up examinations, applying the full
spectrum of DECT applications could lead to a signifi-
cant reduction of radiation dose.
Oncological imaging, a field of increasing socio-
economic relevance, can profit from DECT in several
ways. Patients need repeated imaging for response moni-
toring, and DECT can support efforts for radiation dose
reduction. Furthermore, the spectral information of
DECT data enables tissue characterization and quantifi-
cation of contrast media. This is essential for monitoring
personalized targeted therapies where simple tumour
size measurements are not sufficient [49, 50]. DECT of-
fers additional functional information [18, 19], without
elevated radiation dose.
Conclusion
This study suggests that abdominal dual source DECT is
feasible without increasing radiation dose or image noise
at comparable contrast-to-noise ratios, even compared
to SECT exploiting full potential of dose reduction tech-
niques including automatic voltage control. This is of
special interest in oncology, where patients require re-
peated examinations. Thus DECT can contribute to so-
phisticated oncological imaging without dose penalty.
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